Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael I Luster

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Journal of Immunotoxicology|October 3, 2013
A historical perspective of immunotoxicologyMichael I Luster
Toxicology Letters|December 13, 2006
Genetic susceptibility in pneumoconiosisBerran Yucesoy, Michael I Luster
Toxicology and Applied Pharmacology|July 28, 2004
Arsenic and atherosclerosisPetia P Simeonova, Michael I Luster
Molecular and Cellular Biochemistry|August 7, 2002
Arsenic carcinogenicity: relevance of c-Src activationPetia P Simeonova, Michael I Luster
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2009
Immunotoxicology testing: past and futureMichael I Luster, G Frank Gerberick
Toxicology and Applied Pharmacology|July 28, 2004
Arsenic and urinary bladder cell proliferationMichael I Luster, Petia P Simeonova
Cytokine|August 12, 2004
Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technologyVictor J Johnson, Berran Yucesoy, Michael I Luster
Current Molecular Medicine|February 1, 2003
Cytokine polymorphisms in chronic inflammatory diseases with reference to occupational diseasesBerran Yucesoy, Michael L Kashon, Michael I Luster
Journal of Immunotoxicology|October 30, 2008
Suppression of immune function and susceptibility to infections in humans: association of immune function with clinical diseaseRobert W Luebke, Christine Parks, Michael I Luster
The Journal of Allergy and Clinical Immunology|October 8, 2005
Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthmaVictor J Johnson, Berran Yucesoy, Michael I Luster
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Journal of Immunotoxicology|October 3, 2013
A historical perspective of immunotoxicologyMichael I Luster
Toxicology Letters|December 13, 2006
Genetic susceptibility in pneumoconiosisBerran Yucesoy, Michael I Luster
Toxicology and Applied Pharmacology|July 28, 2004
Arsenic and atherosclerosisPetia P Simeonova, Michael I Luster
Molecular and Cellular Biochemistry|August 7, 2002
Arsenic carcinogenicity: relevance of c-Src activationPetia P Simeonova, Michael I Luster
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2009
Immunotoxicology testing: past and futureMichael I Luster, G Frank Gerberick
Toxicology and Applied Pharmacology|July 28, 2004
Arsenic and urinary bladder cell proliferationMichael I Luster, Petia P Simeonova
Cytokine|August 12, 2004
Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technologyVictor J Johnson, Berran Yucesoy, Michael I Luster
Current Molecular Medicine|February 1, 2003
Cytokine polymorphisms in chronic inflammatory diseases with reference to occupational diseasesBerran Yucesoy, Michael L Kashon, Michael I Luster
Journal of Immunotoxicology|October 30, 2008
Suppression of immune function and susceptibility to infections in humans: association of immune function with clinical diseaseRobert W Luebke, Christine Parks, Michael I Luster
The Journal of Allergy and Clinical Immunology|October 8, 2005
Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthmaVictor J Johnson, Berran Yucesoy, Michael I Luster
Pageof 8